Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Genetics:
o AD inheritance; mutations in PKD1 (85%) or PKD2 (15%)
o PKD1 associated with earlier onset and faster progression to ESRD
• Clinical Features:
o Bilateral renal cysts (from cortex and medulla) → progressive renal enlargement and CKD
o Hypertension (often early finding)
o Haematuria, flank pain, recurrent UTIs or nephrolithiasis
o Berry aneurysms → risk of subarachnoid haemorrhage (screen if FHx)
o Hepatic cysts (common), also pancreatic/splenic cysts
o Mitral valve prolapse, aortic root dilatation
• Diagnosis:
o Renal USS: ≥3 cysts bilaterally in age >40 is diagnostic with +FHx
o MRI for detailed assessment or screening relatives
• Management:
o Blood pressure control: ACEi/ARB preferred
o Tolvaptan (vasopressin V2 antagonist): slows cyst growth and CKD progression in selected patients
o Monitor for complications (e.g. haematuria, infection, ESRD)
o Dialysis/transplant if ESRD develops
Alport Syndrome
• Genetics:
o X-linked (most common), also autosomal dominant/recessive variants
o Defect in type IV collagen
• Clinical Features:
o Persistent microscopic haematuria ± proteinuria
o Progresses to CKD/ESRD in adolescence/young adulthood
o Sensorineural deafness (bilateral, progressive)
o Ocular abnormalities: anterior lenticonus, retinal flecks
o Family history of haematuria and deafness often present
• Diagnosis:
o Electron microscopy: basket-weave appearance of GBM
o Genetic testing may confirm diagnosis
• Management:
o ACE inhibitors to slow progression
o Regular monitoring of renal function and hearing
o Consider transplant in ESRD
Thin Basement Membrane Nephropathy (Benign Familial Haematuria)
• Cause: Thinning of glomerular basement membrane; often familial
• Clinical Features:
o Isolated microscopic haematuria
o Normal renal function; no proteinuria or hypertension
o Excellent long-term prognosis
• Diagnosis:
o EM: thinned GBM
o Often diagnosed after exclusion of other causes
• Management:
o Reassurance; no treatment needed
Medullary Sponge Kidney
• Cause: Congenital dilation of collecting ducts in renal medulla
• Clinical Features:
o Often asymptomatic and discovered incidentally on imaging
o May present with nephrocalcinosis, haematuria, recurrent UTIs or stones
• Diagnosis:
o CT or IVU: characteristic ‘brush-like’ appearance in renal medulla
• Management:
o Conservative; hydration to reduce stone risk
o Treat complications (e.g. stones, infection)
Fabry Disease
• Genetics:
o X-linked lysosomal storage disorder
o Deficiency of α-galactosidase A → accumulation of globotriaosylceramide
• Renal Features:
o Proteinuria, progressive CKD
o May resemble FSGS histologically
• Extra-renal Features:
o Peripheral neuropathy (burning pain)
o Angiokeratomas, hypohidrosis
o Corneal verticillata, cardiac hypertrophy, stroke in young
• Diagnosis:
o α-gal A activity (low in males), genetic testing
o Renal biopsy if diagnosis unclear
• Management:
o Enzyme replacement therapy
o Supportive care (ACEi for proteinuria, pain management)